University of Michigan

Oncology

Dr. Rashmi Chugh, MD

Dr. Rashmi Chugh works in the field of Oncology. He went to Washington University School of Medicine in St. Louis. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Rashmi Chugh, MD is a published doctor. He published 14 publications, including: 'SARC009: Phase 2 study of dasatinib in patients with previously treated, high-grade, advanced sarcoma.'

Publications

Diffuse hypopigmentation followed by hyperpigmentation in an african american woman with hemangiopericytoma treated with dasatinib.
A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyoSarcoma, osteo...
Stress-induced CXCR4 Promotes Migration and Invasion of Ewing Sarcoma.
A Phase I Study of the HSP90 Inhibitor Retaspimycin Hydrochloride (IPI-504) in Patients with Gastrointestinal Stromal Tumors or Soft-Tissue Sarcomas.
Activating ESR1 mutations in hormone-resistant metastatic breast Cancer.
Desmoid Tumors: a comprehensive review of the evolving biology, unpredictable behavior, and myriad of management options.
Undifferentiated Small Round Cell Sarcoma With t(4;19)(q35;q13.1) CIC-DUX4 Fusion: A Novel Highly Aggressive Soft Tissue Tumor With Distinctive Histopathology.
Ewing sarcoma of the kidney: case series and literature review of an often overlooked entity in the diagnosis of primary renal Tumors.
Phase II Trial of Cetuximab in Patients With Metastatic or Locally Advanced Soft Tissue or Bone Sarcoma.
Results of a phase II study of sirolimus and cyclophosphamide in patients with advanced Sarcoma.
Sporadic versus Radiation-Associated Angiosarcoma: A Comparative Clinicopathologic and Molecular Analysis of 48 Cases.
The multidisciplinary management of bone and soft tissue Sarcoma: an essential organizational framework.
SARC009: Phase 2 study of dasatinib in patients with previously treated, high-grade, advanced Sarcoma.

Schools

Washington University In St Louis School Of Medicine

Procedures Preformed

Thoracentesis

Conditions Treated

Adrenal Gland Cancer
Anal and Rectal Cancer
Anemia
Basal Cell Carcinoma
View All

Doctors Specialties

Medical Oncology
Oncology

Accepted Insurances

Awards

CMS Meaningful Use Stage 1 Certification

Education

University of Michigan Hospitals and Health Centers
Washington University School of Medicine in St. Louis

Hospital

University of Michigan Hospitals and Health Centers

Drug Facts

NPI NUMBER		1356427314
NPPES Provider LastName		CHUGH
NPPES Provider FirstName		RASHMI
NPPES Provider ZIPCode		481095912
NPPES Provider State		MI
Specialty Description		Medical Oncology
Total Claim Count		525.0
Distinct Opioid Count		4.0
Opioid Claim Count		79.0
Percent Opioid Claims		15.05

Helpful Reviews

Give Anonymous Review

Medicare Facts

National Provider Identifier [NPI]	1356427314
Last Name Of The Provider	CHUGH
First Name Of The Provider	RASHMI
View All

Similar Doctors

	Dr. Mark M. Zalupski, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Gregory P. Kalemkerian, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Susan G. Urba, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Kathleen A. Cooney, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Kathleen E. Bickel, MD
	Dr. Kunal C. Kadakia, MD This Doctor is OpenDoctor Recommended.
	Dr. Sheetal M. Kircher, MD This Doctor is OpenDoctor Recommended.
	Dr. Moshe Talpaz, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Kemp B. Cease, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Shin L. Mineishi, MD This Doctor is OpenDoctor Recommended.
	Dr. Muneesh Tewari, MD This Doctor is OpenDoctor Recommended.